Investigating Pericyte Roles in Blood-Brain Barrier Formation
研究周细胞在血脑屏障形成中的作用
基本信息
- 批准号:9975931
- 负责人:
- 金额:$ 36.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAlzheimer&aposs DiseaseAstrocytesBMP5 geneBiological AssayBloodBlood - brain barrier anatomyBlood CirculationBlood VesselsBrainBrain DiseasesCellsCharacteristicsDataDemyelinating DiseasesDevelopmentDiseaseDisease modelEmbryoEmbryonic DevelopmentEndothelial CellsEndotheliumEpilepsyFunctional disorderGene Expression ProfileGenerationsGeneticGenomic approachHumanImmuneIn VitroInvadedKnowledgeLaboratoriesLeukocyte Adhesion MoleculesMaintenanceMesodermModelingMolecularMultiple SclerosisMusNeural CrestNeuraxisNeuronsPathologyPathway interactionsPatientsPericytesPeripheralPermeabilityPhenotypePlasma ProteinsPlayProcessPropertyRegulationReportingRoleSignal TransductionSignaling MoleculeSomatic CellStrokeStructureSupplementationSupporting CellSystemTestingTherapeuticTight JunctionsTransport ProcessTraumatic Brain InjuryTubebaseblood-brain barrier functionbrain endothelial cellcell typecohortdevelopmental diseasefetalgenome editinghuman modelimprovedin vitro Modelinduced pluripotent stem cellinnovationinsightmouse modelnervous system disorderneurovascular unitnovelprogenitorprogramsreceptorrestorationstem cell differentiationstem cell technologytooltranscriptometranscriptomicstranscytosis
项目摘要
ABSTRACT
The blood-brain barrier (BBB) acts as a signaling and transport interface between the blood and brain. The
BBB begins to form early in embryonic development as the mesoderm-derived vasculature invades the
immature central nervous system (CNS) and acquires BBB characteristics such as tight junctions and a lack of
fenestrae. After further maturation, the adult BBB, with its very low permeability and a wealth of molecular
transport systems, is maintained by interactions with supporting cells of the neurovascular unit (NVU). Recent
studies have indicated the importance of CNS pericytes in BBB formation, with pericytes triggering reduced
transcytosis, reduced expression of leukocyte adhesion molecules and proper tight junction organization.
However, the identity of pericyte-derived factors that can elicit these important changes during BBB formation
are not known. Thus, our understanding of the molecular mechanisms underpinning BBB formation is
incomplete; and in this proposal, we aim to further examine the mechanisms by which brain pericytes impact
BBB formation. A powerful and innovative approach to explore BBB formation is the use of human induced
pluripotent stem cell (iPSC) technology to model the BBB and the associated support cells of the NVU. We will
demonstrate that not only can brain pericytes be differentiated from iPSCs, they can also regulate key BBB
properties in iPSC-derived brain endothelial cells (BMECs). In parallel, using genomics approaches, we have
identified a cohort of pericyte-derived secreted factors, several of which can induce BBB properties in iPSC-
derived BMECs. Combining these approaches, we will examine the mechanisms whereby pericyte-derived
secreted factors can differentially regulate BBB formation in iPSC-derived BMECs. Preliminary data indicate
that one of the pericyte-derived secreted factors, BMP5, can influence hallmark BBB properties known to be
regulated by brain pericytes. Namely, BMP5 can reduce transcytosis and improve tight junction structures in
iPSC-derived BMECs. To further examine the mechanism by which BMP5 regulates BBB formation during
development, we will use genetic mouse models to explore whether BMP5 signaling is necessary for BBB
formation and function. Finally, we will assess whether BMP5 supplementation can be therapeutic in a mouse
model of multiple sclerosis. Understanding the pericyte-derived regulators of BBB formation could yield many
new mechanistic insights regarding brain diseases that have demonstrable pericyte involvement. Knowledge of
the barrier formation pathways could also open new avenues for restoring BBB function in debilitating
neurological disease.
摘要
血脑屏障(BBB)作为血液和大脑之间的信号和运输界面。的
BBB在胚胎发育早期开始形成,因为中胚层来源的脉管系统侵入了血脑屏障。
不成熟的中枢神经系统(CNS),并获得BBB特征,如紧密连接和缺乏
窗孔进一步成熟后,成熟的血脑屏障具有极低的通透性和丰富的分子量,
运输系统,通过与神经血管单位(NVU)的支持细胞相互作用来维持。最近
研究表明,CNS周细胞在BBB形成中的重要性,周细胞触发降低
细胞转胞吞、白细胞粘附分子表达减少和适当的紧密连接组织。
然而,在血脑屏障形成过程中引起这些重要变化的周细胞源性因子的身份,
不知道。因此,我们对BBB形成的分子机制的理解是
不完整;在这项提案中,我们的目标是进一步研究脑周细胞影响的机制,
BBB形成。探索血脑屏障形成的一种强有力的创新方法是使用人类诱导的
多能干细胞(iPSC)技术来模拟BBB和NVU的相关支持细胞。我们将
证明脑周细胞不仅可以从iPSC分化,它们还可以调节关键的BBB,
iPSC衍生的脑内皮细胞(BMEC)的特性。与此同时,使用基因组学方法,
鉴定了一组周细胞来源的分泌因子,其中几种可以在iPSC中诱导BBB特性,
衍生BMEC。结合这些方法,我们将研究周细胞衍生的细胞凋亡的机制。
分泌的因子可以差异性地调节iPSC衍生的BMEC中的BBB形成。初步数据显示
周细胞来源的分泌因子之一BMP 5可以影响已知的标志性BBB特性,
由脑周细胞调节也就是说,BMP 5可以减少转胞吞作用并改善细胞中的紧密连接结构。
iPSC衍生的BMEC。为了进一步研究BMP 5调节血脑屏障形成的机制,
我们将使用遗传小鼠模型来探索BMP 5信号传导是否是BBB所必需的。
形成和功能。最后,我们将评估BMP 5补充是否可以在小鼠中治疗。
多发性硬化症的模型了解血脑屏障形成的周细胞来源的调节因子可以产生许多
关于脑疾病的新机制的见解,有明显的周细胞参与。知识
屏障形成途径也可能为恢复BBB功能开辟新的途径,
神经系统疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC V SHUSTA其他文献
ERIC V SHUSTA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC V SHUSTA', 18)}}的其他基金
New Human Antibodies for CNS Drug Delivery
用于中枢神经系统药物输送的新型人类抗体
- 批准号:
10581615 - 财政年份:2021
- 资助金额:
$ 36.78万 - 项目类别:
New Human Antibodies for CNS Drug Delivery
用于中枢神经系统药物输送的新型人类抗体
- 批准号:
10208481 - 财政年份:2021
- 资助金额:
$ 36.78万 - 项目类别:
New Human Antibodies for CNS Drug Delivery
用于中枢神经系统药物输送的新型人类抗体
- 批准号:
10376351 - 财政年份:2021
- 资助金额:
$ 36.78万 - 项目类别:
Exploring Blood-Brain Barrier Dysfunction in Alzheimer's Disease
探索阿尔茨海默病中的血脑屏障功能障碍
- 批准号:
10470403 - 财政年份:2018
- 资助金额:
$ 36.78万 - 项目类别:
Investigating Pericyte Roles in Blood-Brain Barrier Formation
研究周细胞在血脑屏障形成中的作用
- 批准号:
10390466 - 财政年份:2018
- 资助金额:
$ 36.78万 - 项目类别:
Exploring Blood-Brain Barrier Dysfunction in Alzheimer's Disease
探索阿尔茨海默病中的血脑屏障功能障碍
- 批准号:
10242177 - 财政年份:2018
- 资助金额:
$ 36.78万 - 项目类别:
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery
能够无创脑部药物输送的七鳃鳗抗体的鉴定
- 批准号:
9920222 - 财政年份:2017
- 资助金额:
$ 36.78万 - 项目类别:
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery
能够无创脑部药物输送的七鳃鳗抗体的鉴定
- 批准号:
10186832 - 财政年份:2017
- 资助金额:
$ 36.78万 - 项目类别:
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery
能够无创脑部药物输送的七鳃鳗抗体的鉴定
- 批准号:
9380557 - 财政年份:2017
- 资助金额:
$ 36.78万 - 项目类别:
RXRalpha and PPARdelta Signaling as Novel Regulators of the Blood-Brain Barrier
RXRalpha 和 PPARdelta 信号作为血脑屏障的新型调节剂
- 批准号:
8660105 - 财政年份:2013
- 资助金额:
$ 36.78万 - 项目类别:














{{item.name}}会员




